“…The inclusion criteria for performing MDCTA in our institution have previously been published and are as follows: the presence of an US examination that showed a pathologic stenosis (NASCET stenosis of Ͼ50% or the presence of a blood flow velocity of Ͼ1.2 m/s) and/or a plaque alteration; or cases in which US cannot provide sufficient information about the degree of stenosis and plaque type-for example, in the presence of large calcified plaques with acoustic shadowing, high carotid bifurcation, or a thick neck (edema, obese patients). 20,21 "Plaque alteration," as visualized by US, was considered as the presence of a heterogeneous plaque, homogeneous soft plaque, an irregular surface, intraplaque hemorrhage, and/or the presence of ulceration in the plaque. In US analysis, we considered an "intraplaque hemorrhage" to be the presence of a plaque containing an echo-poor area.…”